Gastric Ulcer Completed Phase 3 Trials for Esomeprazole (DB00736)

Also known as: Ulcer, Gastric / Gastric ulceration / Gastric Ulcers / Gastric Ulcer (GU) / Stomach Ulcer / Acute gastric mucosal erosion (disorder) / Acute gastric erosions / Acute erosive gastritis (disorder) / Gastric ulcer (disorder) / Ulcer gastric / Ulcus ventriculi / Ulcer stomach

IndicationStatusPhase
DBCOND0031714 (Gastric Ulcer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03553563A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal UlcerPrevention
NCT01129011Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) NaproxenTreatment
NCT00595517Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced UlcerPrevention
NCT00542789Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAIDPrevention
NCT00527904A 12-month, Phase 3, Open-label, Multi-center Study to Evaluate the Long-term Safety of PN400 (VIMOVO)Treatment
NCT00527787Evaluating PN 400 (VIMOVO) in Reducing Gastric Ulcers Compared to Non-steroidal Antiinflammatory Drug (NSAID) NaproxenTreatment
NCT00441727Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)Prevention
NCT00401752Efficacy and Safety Study of Esomeprazole 20mg qd vs Ranitidine 150mg Bid in Patients With an NSAID-induced Gastric UlcerTreatment